HomeBGA • CVE
add
BioNeutra Global Corp
Previous close
$0.10
Year range
$0.0050 - $0.16
Market cap
4.65M CAD
Avg Volume
2.80K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 2.53M | -22.89% |
Operating expense | 1.24M | -4.84% |
Net income | -1.34M | -8.49% |
Net profit margin | -52.70 | -40.72% |
Earnings per share | — | — |
EBITDA | -75.58K | 63.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 791.77K | 7.18% |
Total assets | 15.79M | -32.82% |
Total liabilities | 23.28M | -6.08% |
Total equity | -7.50M | — |
Shares outstanding | 46.70M | — |
Price to book | -0.62 | — |
Return on assets | -5.56% | — |
Return on capital | -753.63% | — |
Cash Flow
Net change in cash
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -1.34M | -8.49% |
Cash from operations | 350.76K | 186.25% |
Cash from investing | -3.42K | 94.98% |
Cash from financing | 242.47K | 619.55% |
Net change in cash | 329.85K | 226.89% |
Free cash flow | 1.21M | — |
About
Founded
1996
Headquarters
Website
Employees
51